Barclays’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5M | Buy |
380,623
+290,997
| +325% | +$14.2M | ﹤0.01% | 848 |
|
|
2025
Q1 | $3.05M | Sell |
89,626
-12,432
| -12% | -$423K | ﹤0.01% | 1751 |
|
|
2024
Q4 | $4.02M | Sell |
102,058
-27,790
| -21% | -$1.09M | ﹤0.01% | 1761 |
|
|
2024
Q3 | $6.1M | Buy |
129,848
+64,228
| +98% | +$3.02M | ﹤0.01% | 1381 |
|
|
2024
Q2 | $3.54M | Sell |
65,620
-190,711
| -74% | -$10.3M | ﹤0.01% | 1346 |
|
|
2024
Q1 | $17.5M | Sell |
256,331
-56,634
| -18% | -$3.86M | 0.01% | 786 |
|
|
2023
Q4 | $19.6M | Sell |
312,965
-197,867
| -39% | -$12.4M | 0.01% | 742 |
|
|
2023
Q3 | $23.2M | Buy |
510,832
+137,629
| +37% | +$6.25M | 0.01% | 644 |
|
|
2023
Q2 | $21M | Buy |
373,203
+11,444
| +3% | +$643K | 0.01% | 668 |
|
|
2023
Q1 | $16.4M | Sell |
361,759
-27,918
| -7% | -$1.26M | 0.01% | 657 |
|
|
2022
Q4 | $15.8M | Buy |
389,677
+280,911
| +258% | +$11.4M | 0.01% | 708 |
|
|
2022
Q3 | $7.11M | Buy |
108,766
+87,117
| +402% | +$5.69M | 0.01% | 935 |
|
|
2022
Q2 | $1.32M | Buy |
21,649
+4,025
| +23% | +$245K | ﹤0.01% | 1870 |
|
|
2022
Q1 | $1.11M | Buy |
17,624
+3,453
| +24% | +$217K | ﹤0.01% | 2231 |
|
|
2021
Q4 | $1.07M | Sell |
14,171
-18,859
| -57% | -$1.43M | ﹤0.01% | 2155 |
|
|
2021
Q3 | $3.7M | Buy |
33,030
+12,006
| +57% | +$1.34M | ﹤0.01% | 1422 |
|
|
2021
Q2 | $3.4M | Buy |
21,024
+15,224
| +262% | +$2.46M | ﹤0.01% | 1409 |
|
|
2021
Q1 | $706K | Sell |
5,800
-13,947
| -71% | -$1.7M | ﹤0.01% | 2480 |
|
|
2020
Q4 | $3.02M | Buy |
19,747
+6,390
| +48% | +$978K | ﹤0.01% | 1327 |
|
|
2020
Q3 | $1.12M | Buy |
13,357
+13,246
| +11,933% | +$1.11M | ﹤0.01% | 1858 |
|
|
2020
Q2 | $8K | Sell |
111
-37
| -25% | -$2.67K | ﹤0.01% | 3666 |
|
|
2020
Q1 | $6K | Sell |
148
-5,161
| -97% | -$209K | ﹤0.01% | 3533 |
|
|
2019
Q4 | $324K | Sell |
5,309
-8,568
| -62% | -$523K | ﹤0.01% | 2923 |
|
|
2019
Q3 | $568K | Buy |
13,877
+4,151
| +43% | +$170K | ﹤0.01% | 2557 |
|
|
2019
Q2 | $459K | Sell |
9,726
-5,073
| -34% | -$239K | ﹤0.01% | 2757 |
|
|
2019
Q1 | $528K | Buy |
14,799
+9,920
| +203% | +$354K | ﹤0.01% | 2580 |
|
|
2018
Q4 | $139K | Sell |
4,879
-7,302
| -60% | -$208K | ﹤0.01% | 2850 |
|
|
2018
Q3 | $541K | Sell |
12,181
-4,590
| -27% | -$204K | ﹤0.01% | 2593 |
|
|
2018
Q2 | $985K | Buy |
16,771
+1,071
| +7% | +$62.9K | ﹤0.01% | 1881 |
|
|
2018
Q1 | $717K | Buy |
15,700
+400
| +3% | +$18.3K | ﹤0.01% | 2037 |
|
|
2017
Q4 | $360K | Buy |
15,300
+3,436
| +29% | +$80.8K | ﹤0.01% | 2310 |
|
|
2017
Q3 | $211K | Buy |
+11,864
| New | +$211K | ﹤0.01% | 2367 |
|